Physician profile
Khristina Ramirez
NPI 1851373971
$820.27
in general payments reported to CMS, 2019-2025
18 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $31.14 · 2021: $129 · 2022: $182 · 2023: $121 · 2024: $77.48 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $188.20 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $101.14 | 2019-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Corium, LLC | $76.01 | 2022-2023 | Azstarys |
| Kaleo, INC. | $58.04 | 2022-2023 | Auvi-Q |
| Sobi, INC | $48.38 | 2022-2023 | Synagis |
| Sanofi Pasteur INC. | $47.57 | 2019 | |
| Supernus Pharmaceuticals, INC. | $47.53 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $41.88 | 2022-2023 | Flumist Quadrivalent |
| Neos Therapeutics, LP | $32.18 | 2019 | |
| Mylan Pharmaceuticals INC. | $30.62 | 2019 | |
| Collegium Pharmaceutical, INC. | $23.59 | 2025 | Jornay Pm |
| Avion Pharmaceuticals | $22.57 | 2023 | Methylphenidate Hydrochloride |
| Ironshore Pharmaceuticals INC. | $20.73 | 2024 | |
| Lnhc, INC | $18.97 | 2025 | Zelsuvmi |
| Sanofi-Aventis U.S. LLC | $17.91 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $17.02 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $16.87 | 2025 | Neffy |
| Pfizer INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khristina Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.